4.6 Article

Development of a nanoparticulate formulation of diminazene to treat African trypanosomiasis

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Human African trypanosomiasis: pharmacological re-engagement with a neglected disease

M. P. Barrett et al.

BRITISH JOURNAL OF PHARMACOLOGY (2007)

Article Pharmacology & Pharmacy

Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro

Youssef Jallouli et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)

Article Pharmacology & Pharmacy

Degradation of berenil (diminazene aceturate) in acidic aqueous solution

M Campbell et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)

Article Pharmacology & Pharmacy

Treatment perspectives for human African trypanosomiasis

B Bouteille et al.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2003)

Article Pharmacology & Pharmacy

Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics

E Cauchetier et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)

Article Chemistry, Analytical

Determination of diminazene aceturate in pharmaceutical formulations by HPLC and identification of related substances by LC/MS

C Atsriku et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)